A network pharmacology-based approach to explore the molecular mechanism of Aidi injection against prostate cancer

A network pharmacology-based approach to explore the molecular mechanism of Aidi injection against prostate cancer

Objective: To explore the molecular mechanism of Aidi injection in the treatment of prostate cancer (PCa). Materials and methods: CCK-8 and colony formation assays were used to detect the effects of Aidi on PC3 and DU145 cells; effects on the cell cycle and apoptosis of DU145 cells were detected by...

Full description

Bibliographic Details
Main Authors:	Sheng Guo, Qiuping Zhang, Xiaolan Li, Xiaoxiang Yu, Taijin Lan, Weiquan Zhang, Yaoyao Han, Xin Chen, Xin Yang, Hongwei Guo
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Heliyon
Subjects:	Prostate cancer Aidi injection Network pharmacology JNK and p38 signaling pathway
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024057517

Similar Items

The potential mechanism of Aidi injection against neuroblastoma—an investigation based on network pharmacology analysis
by: Shuyang Dai, et al.
Published: (2024-01-01)

Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments
by: Haojia Wang, et al.
Published: (2023-01-01)

RETRACTED: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis
by: Qing Fang, et al.
Published: (2023-04-01)

Hishaam D. Aidi. Redeploying the state : corporatism, neoliberalism, and coalition politics. Nueva York : Palgrave Macmillan, 2009. 246 p.
by: Francisco Félix Cárdenas
Published: (2010-04-01)

Infrastructure Development and Economic Growth in East Africa: Quantity versus Quality Dimensions Using Panel-ARDL Approach
by: Tesfaye Etensa, et al.
Published: (2022-12-01)

Asynchronous Pattern of MAPKs’ Activity during Aging of Different Tissues and of Distinct Types of Skeletal Muscle
by: Nechama Gilad, et al.
Published: (2024-01-01)

JNK and p38 gene and protein expression during liver ischemia-reperfusion in a rat model treated with silibinin
by: Nastaran Aamani, et al.
Published: (2022-11-01)

Injection therapy for prostatic disease: A renaissance concept
by: Arash M Saemi, et al.
Published: (2008-01-01)

Neferine inhibits the growth of human osteosarcoma cells through activating P38/JNK and suppressing Wnt/β-catenin signaling pathway
by: Jingtao Xu, et al.
Published: (2022-10-01)

Mechanism of Action of Flavonoids of <i>Oxytropis falcata</i> on the Alleviation of Myocardial Ischemia–Reperfusion Injury
by: Yang Guo, et al.
Published: (2022-03-01)

Network pharmacology and molecular docking study on the mechanism of chronic prostatitis treatment using Xiaochaihutang
by: Jian Wang, et al.
Published: (2023-11-01)

Inhibition of Phosphodiesterase 4 by FCPR03 Alleviates Lipopolysaccharide-Induced Depressive-Like Behaviors in Mice: Involvement of p38 and JNK Signaling Pathways
by: Hui Yu, et al.
Published: (2018-02-01)

Canagliflozin Delays Aging of HUVECs Induced by Palmitic Acid via the ROS/p38/JNK Pathway
by: Wenhui Hao, et al.
Published: (2023-03-01)

Vitamin E Supplementation Enhances Lipid Oxidative Stability via Increasing Vitamin E Retention, Rather Than Gene Expression of MAPK-Nrf2 Signaling Pathway in Muscles of Broilers
by: Lei Xu, et al.
Published: (2021-10-01)

Propofol reduces anoxia-reoxygenation-induced injury of cardiomyocytes
by: CHEN Si, YANG Fu-guo, PENG Hong-jun, CAO Wei-le, WANG Zhen-yu
Published: (2022-04-01)

Network pharmacology and molecular docking-based analysis of protective mechanism of MLIF in ischemic stroke
by: Mengting Lv, et al.
Published: (2022-11-01)

Aspartoacylase suppresses prostate cancer progression by blocking LYN activation
by: Hong Weng, et al.
Published: (2023-06-01)

The Role of <i>G3BP1</i> Gene Mediates P38 MAPK/JNK Pathway in Testicular Spermatogenic Dysfunction Caused by Cyfluthrin
by: Xiao-Yu Li, et al.
Published: (2023-05-01)

Chemical composition, pharmacology and pharmacokinetic studies of GuHong injection in the treatment of ischemic stroke
by: Qiuyue Wang, et al.
Published: (2023-09-01)

Long Non-coding RNA FAM66C Promotes Prostate Cancer Metastasis via JNK-Mediated Proteasome and Lysosomal Pathway
by: Zhenqian Qin, et al.
Published: (2022-12-01)

Intermittent Hypoxia on the Attenuation of Induced Nasal Allergy and Allergic Asthma by MAPK Signaling Pathway Downregulation in a Mice Animal Model
by: Doston Sultonov, et al.
Published: (2022-08-01)

Differential Effects of Overexpression of Wild Type and Kinase-Dead MELK in Fibroblasts and Keratinocytes, Potential Implications for Skin Wound Healing and Cancer
by: Łukasz Szymański, et al.
Published: (2023-04-01)

Picropodophyllotoxin, an Epimer of Podophyllotoxin, Causes Apoptosis of Human Esophageal Squamous Cell Carcinoma Cells Through ROS-Mediated JNK/P38 MAPK Pathways
by: Ah-Won Kwak, et al.
Published: (2020-06-01)

Induction of Melanogenesis by Fosfomycin in B16F10 Cells Through the Upregulation of P-JNK and P-p38 Signaling Pathways
by: Sana Ullah, et al.
Published: (2020-04-01)

MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
by: Petros Moustardas, et al.
Published: (2023-02-01)

GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis
by: Qianwei Zhao, et al.
Published: (2024-01-01)

Pharmacological Effects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia
by: Kensuke Mitsunari, et al.
Published: (2021-01-01)

Network pharmacology-based investigation and experimental validation of the mechanism of scutellarin in the treatment of acute myeloid leukemia
by: Zhe Huang, et al.
Published: (2022-09-01)

Paclitaxel Induces the Apoptosis of Prostate Cancer Cells via ROS-Mediated HIF-1α Expression
by: Yan Zhang, et al.
Published: (2022-10-01)

Exploring the nucleotide molecular mechanism of compound kushen injection for lung adenocarcinoma based on network pharmacology and molecular docking
by: Zhangpeng Ye, et al.
Published: (2022-11-01)

Carbon dioxide and MAPK signalling: towards therapy for inflammation
by: Hanna Gałgańska, et al.
Published: (2023-10-01)

Magnolol Triggers Caspase-Mediated Apoptotic Cell Death in Human Oral Cancer Cells through JNK1/2 and p38 Pathways
by: Yi-Tzu Chen, et al.
Published: (2021-09-01)

Regulation of the Golgi Apparatus by p38 and JNK Kinases during Cellular Stress Responses
by: Cathrine Nordgaard, et al.
Published: (2021-09-01)

Cross talk of c-Jun N-terminal kinase and p38 map kinase modulate insulin and TNFα-stimulated VCAM-1 expression in rat aorta endothelial cells
by: Gregory B. Pott, et al.
Published: (2016-10-01)

c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) are involved in Mycobacterium tuberculosis-induced expression of Leukotactin-1
by: Jang-Eun Cho1, Sangjung Park2, Sang-Nae Cho3, Hyeyoung Lee2 & Yoon Suk Kim2,*
Published: (2012-10-01)

Disruption of prostate epithelial differentiation pathways and prostate cancer development
by: Sander B Frank, et al.
Published: (2013-10-01)

Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity
by: JUAN INOSTROZA, et al.
Published: (2005-01-01)

Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells
by: Sergey A. Dyshlovoy, et al.
Published: (2020-12-01)

Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma
by: Lanyi Wei, et al.
Published: (2024-01-01)

Network pharmacology and experimental investigation of the protective effect of Shuxuetong injection against diabetic nephropathy and encephalopathy in db/db mice
by: Jia Liu, et al.
Published: (2024-02-01)